Hearing DetailsJoint Committee on Public Health

Event Details

Status:

Completed

Event Date:

Wednesday, June 11, 2025

Start Time:

1:00 PM

Location:

A-1 and Virtual

Event Description

Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.

NOTICE OF PUBLIC HEARING

Date of Hearing: Wednesday, June 11, 2025

Time: 1:00 PM – 5:00PM

Location: A1

The Joint Committee on Public Health will conduct a hybrid public hearing in Hearing Room A1 on June 11, 2025, from 1 p.m. to 5 p.m. on bills relating to disease prevention, screening, and treatment, and pharmacies.

Individuals testifying should limit their remarks to 3 minutes. All panels should limit their testimony to a total of 6 minutes.

All matters filed in the House that are listed above are required to be reported on by August 10, 2025, subject to extensions consistent with House Rule 27.

Please be advised that all written testimony submitted will be read by Committee Members and staff and may be made publicly available at the discretion of the Chairs. The committee may limit availability or redact testimony that includes sensitive personal information or information that may jeopardize the health, wellness, or safety of the testifier or others.

The Committee will accept written and oral testimony in-person and virtually.

***INSTRUCTIONS FOR REGISTRATION / TESTIMONY***

LINK TO PRE-REGISTER TO TESTIFY: Persons who wish to testify in person or virtually or submit written testimony may do so by completing this form linked here (https://forms.cloud.microsoft/g/JnNLeG3ku0).

DEADLINE TO PRE-REGISTER: Persons planning to testify virtually must sign up no later than 5:00 p.m. on Tuesday, June 10, 2025. Individuals and groups testifying in person are strongly encouraged to register using the form above prior to the deadline. Registration by the deadline is required for those who wish to testify virtually during the live hearing and encouraged for those who wish to testify in person. Persons who do not have a Google account or do not wish to use the Google form can submit testimony and/or sign up to testify by emailing matthew.murphy@masenate.gov Please indicate whether you plan to testify in person or virtually. Participants who indicate that they plan to testify virtually will receive an invitation to the hearing with instructions via email after the deadline closes.

SAME DAY SIGN-UP FOR IN-PERSON TESTIMONY ONLY – IF TIME ALLOWS: Individuals who miss the deadline to pre-register for testimony may appear on the day of the hearing and sign-up to speak in person on forms provided by committee staff outside of the hearing room. Time permitting, when all pre-registered individuals have been called to testify, the Chairs will then call any individuals who sign-up on the day of the hearing.

WRITTEN TESTIMONY: If you would like to provide written testimony, please include the bill number in the subject line of the email, as well as your name, address, phone number, and organization, if any, on the submitted testimony. Written testimony is encouraged and will continue to be accepted after the hearing until the relevant bill is acted upon. Such testimony may be submitted via email to JointCommittee.PublicHealth@malegislature.gov or physically mailed to the House Chair:

Chair Marjorie C. Decker

Joint Committee on Public Health

ATTN: Ramla Hagi

24 Beacon St., Room 130

Boston, MA 02133

Please include "Public Health Committee Testimony, [Relevant Bill Number]" in the subject line of the email. Those who plan to submit only written testimony may do so before or after the signup deadline.

ORDER OF TESTIMONY: The Chairs, at their discretion, will determine the order of testimony during the course of the hearing. It is the responsibility of the individuals registered to testify to be prepared to speak when called upon by the Chairs. In the event that an individual is called by the Chairs and that person is not logged into the Teams platform, the Chairs will move on and call the next individual or panel.

This hearing will be recorded and archived for later viewing. Those who do not plan to testify but want to watch the public hearing may view the livestream under the Hearings & Events section of the legislative website.

If you have any questions, you may email Ramla.Hagi@mahouse.gov and Matthew.Murphy@masenate.gov.

If you have Accessibility needs, click here.

Item Name	Start Time	Duration	Webcast
Joint Committee on Public Health	6/11/2025 1:00 PM	02:05:47

Agenda

Disease prevention, screening, and treatment, and pharmacies 1:00pm - 5:00pm

Bill	Bill Title	Sponsor
S.1635	An Act authorizing pharmacists to provide opioid use disorder treatment	John C. Velis
S.1630	An Act relative to opting out of fluoridation	Bruce E. Tarr
S.1603	An Act to conduct a public health study of synthetic drugs in the commonwealth	Patrick M. O'Connor
S.1598	An Act establishing a special commission to find the best practices to promote education, awareness, and prevention of Lyme disease	Patrick M. O'Connor
S.1584	An Act to prevent undue influence on prescriber behavior	Mark C. Montigny
S.1583	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Mark C. Montigny
S.1582	An Act improving Hepatitis C screening	Mark C. Montigny
S.1575	An Act providing municipalities to opt out of fluoridation treatments	Paul W. Mark
S.1565	An Act relative to diabetes prevention	Jason M. Lewis
S.1551	An Act establishing a naloxone purchase trust fund	John F. Keenan
S.1550	An Act related to the risk of getting cancer due to the consumption of alcohol	John F. Keenan
S.1545	An Act relative to APOL1 mediated kidney disease	Adam Gómez
S.1538	An Act connecting veterans with access to breakthrough treatments	Dylan A. Fernandes
S.1527	An Act relative to arbovirus in the Commonwealth	Ryan C. Fattman
S.1518	An Act relative to fluoride in water warnings	Peter J. Durant
S.1517	An Act banning artificial fluoridation schemes	Peter J. Durant
S.1508	An Act establishing an amputation prevention task force	Sal N. DiDomenico
S.1497	An Act protecting patient safety regarding non-FDA approved drugs	John J. Cronin
S.1495	An Act relative to healthcare worker and first responder safety	John J. Cronin
S.1479	An Act to clarify prescription monitoring program activities	William N. Brownsberger
S.1478	An Act to reduce the risks associated with allergic reactions	William N. Brownsberger
H.4022	Resolve providing for the study and investigation relative to the efficacy of alternative treatments for veterinary medicine	James C. Arena-DeRosa
H.2549	An Act relative to fluoride in water warnings	Justin Thurber
H.2548	An Act banning artificial fluoridation schemes	Justin Thurber
H.2535	An Act establishing a Naloxone Purchase Trust fund	Greg Schwartz
H.2509	An Act relative to the availability of prescription medication during an emergency	Edward R. Philips
H.2503	An Act to reduce the risks associated with allergic reactions	John Francis Moran
H.2502	An Act to clarify prescription monitoring program activities	John Francis Moran
H.2457	An Act relative to fentanyl testing	Bradley H. Jones, Jr.
H.2449	An Act providing municipalities to opt out of fluoridation treatments	Natalie M. Higgins
H.2447	An Act authorizing a 90-day supply of medically necessary testosterone therapy medication	Natalie M. Higgins
H.2441	An Act relative to diabetes prevention	Richard M. Haggerty
H.2435	An Act relative to APOL1 mediated kidney disease	Homar Gómez
H.2433	An Act to establish an amputation prevention task force	Jessica Ann Giannino
H.2422	An Act relative to Parkinson's Disease public awareness and education	William C. Galvin
H.2417	An Act relative to medical sharps stewardship	Carole A. Fiola
H.2416	An Act relative to gambling addiction	Carole A. Fiola
H.2413	An Act recognizing EMS as a disease dangerous to the public health, requiring inclusion in MAVEN, establishing the Massachusetts EMS registry and requiring biennial reporting as part of population health trends	Tricia Farley-Bouvier
H.2411	An Act reducing non-ionizing radiation in early to higher education	Patricia A. Duffy
H.2406	An Act relative to health care worker and first responder safety	Daniel M. Donahue
H.2404	An Act relative to increased availability of opioid antagonist medication	Kate Donaghue
H.2385	An Act establishing a special commission on avian influenza (H5N1)	Leigh Davis
H.2377	An Act to improve patient access to prescription medication	Nicholas A. Boldyga
H.2372	An Act relative to collaborative drug therapy management optimization	Christine P. Barber
H.1374	An Act establishing a state-wide drug repository program	Bradley H. Jones, Jr.
H.2472	An Act protecting patient safety regarding non-FDA approved drugs	Kathleen R. LaNatra

Hearing DetailsJoint Committee on Public Health

Search